Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa

Clinical and Experimental Allergy

Volumn 27, Issue 5, 1997, Pages 552-558

  Hallen H ^a   Enerdal, J ^a   Graf, P ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

acoustic rhinometry; fluticasone propionate; PNIF; rhinitis medicamentosa; rhinostereometry

Indexed keywords

CITALOPRAM; FLUTICASONE PROPIONATE; NOSE SPRAY; OMEPRAZOLE; OXYMETAZOLINE; PAROXETINE; PLACEBO; XYLOMETAZOLINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MALE; NOSE OBSTRUCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINOMETRY; STEREOMETRY; SYMPATHETIC NERVE;

ADMINISTRATION, INTRANASAL; ADULT; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INSPIRATORY CAPACITY; MALE; MIDDLE AGED; NASAL MUCOSA; RHINITIS; SKIN TESTS;

EID: 0030994631     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb00744.x     Document Type: Article

References (18)

1. Baldwin R. Rhinitis medicamentosa (an approach to treatment). J Med Assoc State Ala 1977; 47:33-5.
2. Toohill R, Lehman R, Grossman T, Belson T. Rhinitis medicamentosa. Laryngoscope 1981; 91:1614-21.
3. Graf P, Juto J-E. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline. ORL 1994; 56:131-4.
4. Graf P, Hallén H, Juto J-E. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers. Clin Exp Allergy 1995; 25:395-400.
5. Åkerlund A, Bende M. Sustained use of xylometazoline nose drops aggravates vasomotor rhinitis. Am J Rhinol 1991; 5(4):157-60.
6. Berridge T, Roach A. Characterization of alpha-adrenoreceptors in the vasculature in the canine nasal mucosa. Br J Pharmacol 1986; 88:345-54.
7. Scadding G. Rhinitis medicamentosa. Clin Exp Allergy 1995; 25:391-4.
8. Feinberg A, Feinberg S. The 'nose drop nose' due to oxymetazoline (Afrin) and other topical vasoconstrictors. Ill Med J 1971; 140(1):50-2.
9. Kumlien J. Rhinitis medicamentosa, a resurrected disease? Läkartidningen 1991; 88:4117.
10. Juto J-E, Lundberg C. An optical method for determining changes in mucosal congestion in the nose in man. Acta Otolaryngol (Stockh) 1982; 94:149-56.
11. Jackson A, Butler J, Miller E, Hopin F, Dawson S. Airway geometry by analysis of acoustic pulse response mesurements. J. Appl Physiol 1977; 43:523-36.
12. Hilberg O, Jackson A, Swift D, Pedersen O. Acoustic rhinometry: evaluation of nasal cavity geometry by acoustic reflection. J Appl Physiol 1989; 66:295-303.
13. Benson MK. Maximal nasal inspiratory flow rate. Its use in assessing the effect of pseudoephedrine in vasomotor rhinitis. Eur J Clin Pharmacol 1971; 3:182-4.
14. Gleeson M, Youlten L, Shelton D, Siodlak M, Eiser N, Wengraf C. Assessment of nasal airway patency: a comparison of four methods. Clin Otolaryngol 1986; 11:99-107.
15. Rijntjes E. Nose-drop abuse, a functional and morphological study. Leiden: University of Leiden, 1985.
16. Nathan R, Bronsky E, Fireman P et al. Once daily fluticacone proprionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis. Ann of Allergy 1991; 67:332-8.
17. Lekas M. Rhinitis during pregnancy and rhinitis medicamentosa. Otolaryngol Head Neck Surgery 1992; 107:845-9.
18. Graf P, Hallén H, Juto J-E. The pathophysiology and treatment of rhinitis medicamentosa. Clin Otolaryngol 1995; 20:224-9.